Tampa Office Market Analysis: Amgen Moves In
The $25 million dollar office investment biotech giant Amgen has made in the Westshore business district of Tampa is touted to bring over 400 high-paying jobs to the Sunshine State. The California-based company’s plan to open a “capability center” — a kind of business support and operations facility — will occupy four floors of Corporate Center One, at 2202 N. Westshore Blvd., taking up over 125KSF. The facility will open in October of 2017.
What made up the Tampa office market environment that Amgen’s property professionals liked? Competitors, talent and options. On the competition front, other biotech and pharma giants have digs in Tampa, including Squibb, Bristol-Meyers and Johnson & Johnson. Surely the location of so many highly-trained pharma and tech professionals living in and around Tampa metro sweetened the deal for Amgen.
Westshore: Market Snapshot
On the office property front, Tampa’s CBD is marked by options in Class A and B properties, plus a sliding vacancy rate, as specified by Xceligent’s 4Q2016 Tampa Office Market Report. The report shows the Westshore submarket where Amgen settled to be the largest source of deal activity. The submarket sported five of the top eight lease transactions in the quarter, with inventory for the submarket adding up to over 14M SF, the largest number on offer in Tampa. Westshore’s vacancy rate is pegged at 8.4%, according to the report.
CommercialSearch: Properties listed in Tampa’s Westshore Submarket
Check out the office and industrial properties listed today at CommercialSearch.com located in the Westshore submarket of Tampa by clicking the link. Total number today: 113 listings on offer, ranging from A, B and C class properties.
As always: to obtain a free copy of the latest Tampa Office Market Report from Xceligent, click here to drop us a line.
(Photo credit: BizJournals.com)